AMRX
Amneal Pharmaceuticals, Inc.
19.30$
-0.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.5% | +6.8% | +6.5% | +0.1% | +4.0% | -4.8% | +4.2% | +8.3% | +3.8% | -11.3% | +10.2% | – | |
| – | +1.0% | +7.6% | +7.3% | -4.2% | +8.0% | -6.0% | -0.3% | +16.5% | +1.3% | -22.2% | +14.7% | – | |
| – | -3.0% | +5.6% | +5.0% | +7.8% | -2.5% | -2.7% | +11.9% | -4.3% | +8.5% | +7.7% | +4.5% | – | |
| – | +10.2% | -15.6% | -5.6% | +64.7% | -8.2% | -25.5% | +19.6% | +26.8% | -45.0% | +10.2% | +7.1% | – | |
| – | -14.5% | +16.6% | +3.4% | +1.9% | -20.6% | +25.5% | +5.1% | +10.9% | +6.3% | +27.4% | -20.3% | – | |
| – | +34.7% | +17.8% | -37.9% | +17.0% | +3.5% | -16.9% | +12.4% | +56.7% | -33.3% | -3.0% | +6.4% | – | |
| – | -81.2% | -175.7% | – | -7.0% | -14.7% | +32.4% | +11.0% | -100.1% | – | +24.8% | +2.2% | – | |
| – | +17.0% | +10.3% | +0.0% | -0.3% | -5.9% | -7.7% | +14.3% | -3.5% | -10.5% | -5.1% | +3.2% | – | |
| – | -463.6% | – | – | -24.4% | -199.3% | – | +37.9% | -110.1% | – | +45.2% | -11.5% | – | |
| – | – | -37.7% | -41.2% | +1.3% | +47.9% | +137.3% | +25.1% | -245.1% | – | -61.6% | -36.8% | – | |
| – | -1,118.9% | – | – | -102.6% | – | – | +83.8% | -89.4% | +1,380.6% | +77.5% | -7.4% | – | |
| – | -74.8% | +38.4% | +210.0% | -1.3% | -19.6% | +37.4% | +14.5% | -36.9% | +43.9% | +15.8% | +4.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.